Harvard Bioscience Stock
Your prediction
Harvard Bioscience Stock
We can see a decrease in the price for Harvard Bioscience. Compared to yesterday it has lost -€0.040 (-1.390%).
Pros and Cons of Harvard Bioscience in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Harvard Bioscience vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Harvard Bioscience | -1.390% | -5.960% | -12.883% | -46.916% | -40.586% | -50.609% | 40.455% |
MicroVision Inc | 2.260% | 0.019% | -24.901% | -71.797% | -57.893% | -91.792% | 47.694% |
Fonar Corp. New | -0.710% | 0.000% | -13.125% | -13.125% | -21.469% | -6.081% | -23.492% |
Fluidigm Corp. | - | -0.862% | 6.481% | 0.000% | 11.650% | -50.538% | - |
Comments
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HBIO provided by MarketBeat
News
2 Reasons Amazon Stock Is a Buy and Hold Forever
Amazon (NASDAQ: AMZN) is one of the largest companies on earth. For much of the world, especially the U.S., it's difficult to go a day without seeing one of the company's drivers making a delivery
Social Security Has a Big Immigration Problem -- but It's Probably Not What You Think
A recent survey conducted by the Nationwide Retirement Institute revealed that retirees view inflation and potential Social Security benefit cuts as their biggest concerns. And the Harvard